Noctrix Health Raises $33.5M and Expands Leadership Team to Accelerate U.S. Commercialization of Nidra(R) Therapy for Restless Legs Syndrome (RLS) Aug 29 Written by Tunde Oshinowo Reported by Access Newswire | August 29, 2025https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/noctrix-health-raises-33.5m-and-expands-leadership-team-to-accelerate-1066896 Tunde Oshinowo Previous Previous HealthEdge and UST HealthProof Merge, Creating Disruptive AI-Powered, Healthcare Payer Technology and Services Leader Next Next Tuesday Health Locked Up $60 Million Strategic Investment
Noctrix Health Raises $33.5M and Expands Leadership Team to Accelerate U.S. Commercialization of Nidra(R) Therapy for Restless Legs Syndrome (RLS) Aug 29 Written by Tunde Oshinowo Reported by Access Newswire | August 29, 2025https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/noctrix-health-raises-33.5m-and-expands-leadership-team-to-accelerate-1066896 Tunde Oshinowo
